Product Information
GLYBURIDE 2.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0759 per EA under NDC 00093943305. Its NADAC has been published 588 times since Nov 28, 2013.
FDA first approved this application on May 1, 1984. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093943305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
GLYBURIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017532FDA Approved
5/1/1984
TE Code
AB2
On Market Since
5/1/1984
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 2.5 MG TABLET has been published 588 times since Nov 28, 2013, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0759 per EA |
|---|---|
| All-time high | $0.1515 (May 11, 2016) |
| All-time low | $0.0548 (May 22, 2024) |
| Median price | $0.0973 |
| Average price | $0.1017 |
| Largest weekly change | +67.8% (Jun 19, 2024) |
| Weeks tracked | 588 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-5.7%
5Y
-23.8%
All
-36.6%
Last surveyed Feb 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 2.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0759 per EA (NDC 00093943305), effective Feb 26, 2025.
How has the price of GLYBURIDE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 2.5 MG TABLET has declined 36.6%. It has been tracked across 588 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYBURIDE 2.5 MG TABLET has ranged from a low of $0.0548 (May 22, 2024) to a high of $0.1515 (May 11, 2016), with a median of $0.0973 per EA.
Are there cheaper alternatives to GLYBURIDE 2.5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE 2.5 MG TABLET, is $0.0668 per EA — about 12% below GLYBURIDE 2.5 MG TABLET.
Who manufactures GLYBURIDE 2.5 MG TABLET?
GLYBURIDE 2.5 MG TABLET (NDC 00093943305) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.